Archive | Featured

Exact Sciences

UPDATE: New $60 million corporate headquarters is proposed for Exact Sciences

With major expansion projects already underway at several of its Madison-area sites, Exact Sciences Corp. is also in line for a new corporate headquarters at University Research Park that could add 200 to 440 new jobs there over the coming years. Aaron Olver, director of University Research Park, said the organization proposes to build a […]

Continue Reading

WisBusiness: Bioscience industry on the rise in Wisconsin

The state’s bioscience industry is on the rise, employing nearly 35,000 in 2016. That’s according to a new report from the national Biotechnology Innovation Organization, which highlights the $2 trillion impact the industry has on the country as a whole. It shows Wisconsin has been performing above the national average for bioscience employment, with a […]

Continue Reading
Cellular Dynamics

Fujifilm Cellular Dynamics says it will make brain cells that can boost research on Alzheimer’s

A Madison stem cell company plans to manufacture specialized brain cells that it says could help researchers create a path toward better drugs to treat Alzheimer’s and other neurological diseases. Fujifilm Cellular Dynamics Inc. has signed an agreement with the University of California-Irvine for an exclusive license to a patent for creating microglia cells, a […]

Continue Reading
Wisconsin Governor's Business Plan Contest

UW spinoffs win awards, including top honor, at Governor’s Business Plan Contest

A University of Wisconsin–Madison spinoff won the grand prize and three others won top awards in their categories in the 15th annual Governor’s Business Plan Contest on Wednesday. The grand prize went to NovoMoto, a social enterprise company that packages and sells solar lighting systems under an innovative rent-to-own program in the Democratic Republic of […]

Continue Reading

AmebaGone uses benign organisms to attack pathogens in production crops

Protecting production crops against bacterial invasion is an eternal struggle for agriculture. Antibiotics can’t address everything that poses a threat, and many pathogens have evolved to become resistant to antibiotics. Novel ways to address bacterial pathogens must be developed to keep crops safe and available for consumption. In 2010, a group of five people had […]

Continue Reading

Invenra Partners with Exelixis to Develop New Antibody Cancer Drugs

Invenra, a URP tenant / biotech startup that develops therapeutic antibodies for pharma companies, is joining forces with a Bay Area company to discover and develop new treatments for cancer. Under the agreement, Exelixis will pay Invenra $2 million upfront, plus an additional $2 million at the outset of each new discovery project, the company […]

Continue Reading